Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?

Autor:	Devi J; Department of Gastroenterology, Liaquat University of Medical and Health Sciences, Jamshoro 74800, Pakistan., Raees A; Department of Gastroenterology, Aga Khan University Hospital, Karachi 74800, Pakistan., Butt AS; Department of Gastroenterology, Aga Khan University Hospital, Karachi 74800, Pakistan. amna.subhan@aku.edu.
Jazyk:	angličtina
Zdroj:	World journal of hepatology [World J Hepatol] 2022 Jan 27; Vol. 14 (1), pp. 158-167.
DOI:	10.4254/wjh.v14.i1.158
Abstrakt:	Recently, a single letter change has taken the world by storm. A group of experts have developed a consensus to upgrade the term non-alcoholic fatty liver disease (NAFLD) to metabolic associated fatty liver disease (MAFLD), suggesting that MAFLD would more accurately reflect not only the disease pathogenesis but would also help in patient stratification for management with NAFLD. However, the difference of opinion exists, which has made the NAFLD vs MAFLD debate the current talk of the town. This review will focus on the plausibility and implications of redefining NAFLD as MAFLD. Competing Interests: Conflict-of-interest statement: The authors have nothing to disclose. (©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu